Skip to main content
. 2014 Aug 20;2:18–22. doi: 10.5414/CNCS108253

Table 1. Laboratory parameters and therapeutic interventions.

Case 1 Case 2
Vital signs
   Pulse (beats/min) 114 69
   BP (mmHg) 127/92 134/58
Laboratory parameters
   Baseline SCr (0.5 – 1.4 mg/dL) NA 0.8
   Admission SCr (mg/dL) 0.9 0.9
   Peak SCr (mg/dL) 1.1 0.9
   Hemoglobin (11.6 – 14.6 g/dL) 14.3 13.8
   Platelets (156 – 369 k/cumm) 262 211
   Pre-HDaPTT (22.7 – 35.6sec) 38.2 36.5
   Post-HD aPTT (sec) 33.2 26.3
   Pre-HD TT (16 – 22 sec) >150 >150
   Post-HD TT (sec) 60 39.3
   Pre-HD INR (0.8 – 1.2) 1.4 1.2
   Post-HD INR 1.0 0.9
   Pre-HD dabigatran (ng/dL) 123 41
   Post-HD dabigatran (ng/dL) < 40 <40
Therapeutic interventions
   Platelets (units) None 1
   rFactor VII (mg) 3 2.5
   HD duration (hours) 4 4
   QD (mL/min) 800 800
   QB (mL/min) 400 400
   HD catheter Left femoral Right femoral

BP = blood pressure; SCr = serum creatinine; HD = hemodialysis; aPTT = activated partial thromboplastin time; PT = prothrombin time; INR = international normalization ratio; TT = thrombin clotting time; rFactor VII = recombinant Factor VII; QD = dialysate flow rate; QB = blood flow rate; NA = not available.